South Africa's Aspen Sells Infant Formula Business To Lactalis
African drugmaker Aspen Pharmacare has agreed to sell its infant formula business to French dairy group Lactalis for 12.9 billion rand (€750 million), looking to capitalise on the sector's recent flurry of dealmaking to reduce its debt and focus on core operations.
Investors, however, appeared unimpressed with the price tag.
Shares in Aspen dropped more than 9% to 245.85 rand after Africa's biggest manufacturer of generic drugs announced the deal as it reported full-year earnings.
Try European Supermarket Magazine PREMIUM – 30 Day FREE Trial.
A trial subscription gives unrestricted access to all premium site content, app content, weekly email content and European Supermarket Magazine digital edition for a full 30 days. Try it now!